ENSC
Ensysce Biosciences, Inc.
$0.28
-0.02 (-6.44%)
At close · Jul 7
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$4.04M
Shares
14,694,492
Earnings calls and other investor events (conferences, investor days) grouped as single events — the transcript and audio, plus, for earnings calls, the 8-K earnings release and the quarter's 10-Q or 10-K, with the reported result and management tone at a glance.
Revenue & result across quarters
Revenue ($B) YoY up YoY down artefacts
LATEST
▼27.2%
'26 Q1
26-05-18
▲44.4%
'25 Q4
26-03-30
▼85.6%
'25 Q3
25-11-14
▲654.4%
'25 Q2
25-08-13
▲331.7%
'25 Q1
25-05-13
▲153.1%
'24 Q4
25-03-10
▲685.3%
'24 Q3
24-11-12
▼62.9%
'24 Q2
24-08-14
▼61.3%
'24 Q1
24-05-13
▼64.1%
'23 Q4
24-03-15
▲55.9%
'23 Q3
23-11-09
▲136.4%
'23 Q2
23-08-11
▼12.3%
'22 Q4
23-03-31
▼53.3%
'22 Q2
22-08-11
▲140.7%
'22 Q1
22-05-12
·
'21 Q4
22-03-31
Earnings call
FY26 · Q1
2026-05-18
Ensysce Biosciences, Inc. Q1 FY2026 Earnings Call
Revenue
$960,999
▼ 27.2% YoY Diluted EPS
$-0.52
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-30
Ensysce Biosciences, Inc. Q4 FY2025 Earnings Call
Revenue
$1.88M*
▲ 44.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-14
Ensysce Biosciences, Inc. Q3 FY2025 Earnings Call
Revenue
$493,104
▼ 85.6% YoY Diluted EPS
$-1.29
▼ 229% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Ensysce Biosciences, Inc. Q2 FY2025 Earnings Call
Revenue
$1.37M
▲ 654.4% YoY Diluted EPS
$-0.79
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Ensysce Biosciences, Inc. Q1 FY2025 Earnings Call
Revenue
$1.32M
▲ 331.7% YoY Diluted EPS
$-1.39
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-10
Ensysce Biosciences, Inc. Q4 FY2024 Earnings Call
Revenue
$1.30M*
▲ 153.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Ensysce Biosciences, Inc. Q3 FY2024 Earnings Call
Revenue
$3.42M
▲ 685.3% YoY Diluted EPS
$1.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Ensysce Biosciences, Inc. Q2 FY2024 Earnings Call
Revenue
$181,797
▼ 62.9% YoY Diluted EPS
$-3.35
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Ensysce Biosciences, Inc. Q1 FY2024 Earnings Call
Revenue
$305,722
▼ 61.3% YoY Diluted EPS
$-8.21
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-15
Ensysce Biosciences, Inc. Q4 FY2023 Earnings Call
Revenue
$515,033*
▼ 64.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Ensysce Biosciences, Inc. Q3 FY2023 Earnings Call
Revenue
$435,380
▲ 55.9% YoY Diluted EPS
$-13.05
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-11
Ensysce Biosciences, Inc. Q2 FY2023 Earnings Call
Revenue
$490,472
▲ 136.4% YoY Diluted EPS
$-14.70
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-31
Ensysce Biosciences, Inc. Q4 FY2022 Earnings Call
Revenue
$1.43M*
▼ 12.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q2
2022-08-11
Ensysce Biosciences, Inc. Q2 FY2022 Earnings Call
Revenue
$207,471
▼ 53.3% YoY Diluted EPS
$-847.35
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Ensysce Biosciences, Inc. Q1 FY2022 Earnings Call
Revenue
$603,098
▲ 140.7% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-31
Ensysce Biosciences, Inc. Q4 FY2021 Earnings Call
Revenue
$1.64M*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-16
Ensysce Biosciences, Inc. Q3 FY2021 Earnings Call
Revenue
$1.20M
▲ 45.1% YoY Diluted EPS
$-2556.00
▼ 888.9% YoY
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-17
Ensysce Biosciences, Inc. Q2 FY2021 Earnings Call
Revenue
$444,516
▼ 75.6% YoY
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–18 of 18 earnings calls